tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (PL:SVE)
:SVE

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Revenue

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 4.79M in the quarter ending Sep 30, 2025, with -23.79%. This bring the company's revenue in the last twelve months to 53.75M, Increased -13.82%. In the fiscal year ending Dec 31, 2024, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 71.76M with 22.44% growth.
Revenue (ttm)
53.75M
Revenue Growth
P/S Ratio
4.42
Revenue/Employee
zł300,234
Employees
239
Market Cap
zł317.10M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
71.76M13.15M+122.44%
Dec 31, 2023
58.61M8.22M+116.32%
Dec 31, 2022
50.38M9.23M+122.43%
Dec 31, 2021
41.15M995.00K+102.48%
Dec 31, 2020
40.16M1.05M+102.69%
Dec 31, 2019
39.11M6.81M+121.10%
Dec 31, 2018
32.29M889.00K+102.83%
Dec 31, 2017
31.40M-4.93M+86.42%
Dec 31, 2016
36.34M